CNS Pharmaceuticals
CNSP
CNSP
16 hedge funds and large institutions have $425K invested in CNS Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
Holders
16
Holders Change
+4
Holders Change %
+33.33%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
2
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AC
1
Armistice Capital
New York
|
$155K |
| 2 |
SAF
2
Smith Anglin Financial
Dallas,
Texas
|
$63.5K |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$74.1K |
| 4 |
VF
4
Virtu Financial
New York
|
$17K |
| 5 |
5
Renaissance Technologies
New York
|
$14K |
